Latest ABUS reports update at 2024-05-02: 2024-Q1 ∙ 2023-Q4 ∙ 2023-Q1

Arbutus Biopharma Corporation ABUS

$ 3.09 -0.32%

Arbutus Biopharma Corporation Total Liabilities 2011-2024 | ABUS

Annual Total Liabilities Arbutus Biopharma Corporation

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
38.4 M	58.6 M	35 M	35.1 M	32.8 M	27.7 M	54.7 M	72.9 M	165 M	30.1 M	12.5 M	11.7 M	8.5 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
165 M	8.5 M	44.8 M

Quarterly Total Liabilities Arbutus Biopharma Corporation

2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
35.7 M	38.4 M	39.3 M	42.1 M	47.3 M	58.6 M	58.3 M	-	71 M	35 M	35.5 M	34.5 M	32.1 M	35.1 M	35.1 M	35.1 M	35.1 M	32.8 M	32.8 M	32.8 M	32.8 M	27.7 M	27.7 M	27.7 M	27.7 M	54.7 M	54.7 M	54.7 M	54.7 M	72.9 M	72.9 M	72.9 M	72.9 M	165 M	165 M	165 M	165 M	30.1 M	30.1 M	30.1 M	30.1 M	12.5 M	12.5 M	12.5 M	12.5 M	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
165 M	12.5 M	51.1 M